To address patient demand, SFJ Pharmaceuticals closes the acquisition of Bentracimab
Medical and Pharma Insider
Medical - Pharma - Biotech - Medical Devices - Healthcare - Telemedicine - Healthcare Technology - Healthcare IT
Your Source For Worldwide Business and Financial Opportunities
-
MedNews on financings, strategic relationships, products, services and technology, including launches
-
MedTalks videos featuring conversations with management of companies with business or financial objectives
.jpg)
Clinical
Trials





- Jan 4
- 3 min
Apnimed Closes $79.75 Million for Phase 3 Trials of an Oral Medication for Obstructive Sleep Apnea

- Dec 27, 2022
- 2 min
Ablaze Pharmaceuticals and Yonghe Pharma to develop targeted radiopharma therapies


- Dec 22, 2022
- 4 min
University Hospitals Performs First Arthroscopic Surgeries in Ohio using ArthroFree Wireless Camera


- Nov 23, 2022
- 3 min
scPharmaceuticals Announces Pricing of $50 Million Public Offering


- Nov 5, 2022
- 3 min
H.I.G. Capital acquires leading global clinical research organization Celerion


- Oct 15, 2022
- 4 min
Integrated Drug Development Solution Company Altasciences Expands Support for Early Drug Development


- Oct 8, 2022
- 4 min
RadioMedix raises $40 million to advance its alpha therapy platform for oncology


- Oct 2, 2022
- 4 min
CXL Ophthalmics announces $32 Million investment to advance its treatment for keratoconus

- Sep 28, 2022
- 3 min
Aqualung Therapeutics Receives FDA Clearance of its IND for Acute Respiratory Distress Syndrome

- Sep 27, 2022
- 2 min
SeraNovo and Ildong Pharmaceutical to Collaborate on Multi-Compound Research Projects


- Sep 1, 2022
- 3 min
OKYO plans fourth quarter IND filing for drug candidate to treat dry eye disease


- Aug 13, 2022
- 2 min
Clario invests in new technology to reduce translation times for clinical trials


- Aug 5, 2022
- 2 min
Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy

- Aug 3, 2022
- 3 min
IDRx raises $122 million to transform cancer treatment with precision combination therapies


- Jul 29, 2022
- 3 min
HempMy Pet and Tarleton University announce positive results of their study using CBD on horses


- Jul 11, 2022
- 3 min
FIRST IN HUMAN SUBJECTS ENROLLED IN AQUALUNG THERAPEUTICS PHASE 1A STUDY OF ALT-100


- Jul 9, 2022
- 4 min
Kernal Biologics Raises $25 Million to Advance its mRNA 2.0 Technology for Oncology


- Jun 5, 2022
- 3 min
Imaging Endpoints and ImaginAb partner to supply doses of the CD8 imaging agent for clinical trials


- May 14, 2022
- 7 min
Mitsubishi Tanabe Pharma America obtains FDA approval of its RADICAVA ORS for the treatment of ALS

- May 7, 2022
- 2 min
Sen-Jam Pharmaceutical Enrolls Patients in its COVID Therapy Phase 2 Clinical Trial

- May 4, 2022
- 3 min
Four pharma solution providers launch Norstella to provide faster patient access to therapies

- Apr 15, 2022
- 4 min
With new funding, Pictor partners with Mobility Health for a SARS-CoV-2 antibody test

- Apr 7, 2022
- 2 min
ENDOVASCULAR ENGINEERING CLOSES ON $15 MILLION FOR VENOUS THROMBECTOMY SOLUTIONS


- Mar 26, 2022
- 3 min
Geneos Therapeutics closes on $17 million to advance its personalized cancer immunotherapy platform


- Mar 24, 2022
- 3 min
Sen-Jam Pharmaceutical partners with KVK Tech for Covid oral therapeutic


- Mar 21, 2022
- 3 min
Triumvia Immunologics completes $100 million round for its T cell therapeutics


- Mar 2, 2022
- 2 min
Alcami, the contract development and manufacturer adds formulation development laboratory


- Feb 28, 2022
- 4 min
Algernon Pharmaceuticals starts chronic kidney disease research program

- Feb 19, 2022
- 2 min
Dizal Pharmaceutical obtains FDA Fast Track Designation for its drug for Refractory T-Cell Lymphoma


- Feb 14, 2022
- 5 min
Otsuka and Sunovlon start Phase 3 trials for a treatment for biopolar depression


- Feb 12, 2022
- 4 min
Orthox raises $12.5 million to begin clinical trials for knee cartilage repair


- Feb 7, 2022
- 3 min
Third Pole Therapeutics closes on $25 million for trials of its wearable medical device for COPD


- Feb 6, 2022
- 2 min
Paraxel and Dassault's Medidata extend partnership to improve decentralized clinical trials


- Feb 2, 2022
- 5 min
4D pharma announces positive data from Part A of its Phase I/II trial for the treatment of asthma

- Jan 31, 2022
- 3 min
PrecisionLife closes on financing to advance its AI-led drug discovery for precision medicine


- Jan 25, 2022
- 2 min
KalVista Pharmaceuticals (NASDAQ: KALV) publishes data on its trials for hereditary angioedema


- Jan 24, 2022
- 4 min
BenchSci closes on $63 million to expand machine learning technology for pharmacelutical companies


- Jan 22, 2022
- 2 min
Parity Technologies partners with MediLedger Network to bring blockchain solutions to life sciences


- Jan 21, 2022
- 4 min
Yingli Pharma and MD Anderson partner for preclinical and clinical oncology programs


- Jan 15, 2022
- 2 min
RealTime, the clinical research technology leader raises growth funding

- Jan 6, 2022
- 3 min
Avenge Bio raises $48 million to advance research for treatment of ovarian cancer


- Dec 24, 2021
- 3 min
Oncorena lands financing for its clinical study for patients with advanced kidney cancer


- Dec 23, 2021
- 2 min
Cardiovascular startup Filterlex Medical receives €7M from the European Innovation Council

- Dec 10, 2021
- 4 min
Iterion Therapeutics starts phase 1 clinical trial for non-small cell lung cancer


- Nov 25, 2021
- 3 min
Lixte Biotechnology (Nasdaq: LIXT) resumes enrollment for its trial for recurrent, malignant tumors

- Nov 21, 2021
- 3 min
Healint and Nestle Health Science Partners initate a virtual study on ketogenic migraine treatment


- Nov 19, 2021
- 3 min
Alpheus Medical raises $16 million for human trials of therapy for solid body cancers


- Nov 6, 2021
- 3 min
Preclinical Parthenon Therapeutics closes on $65 million to advance anti-cancer therapeutics


- Oct 14, 2021
- 3 min
Contract Research Organization Sai Life Sciences expands capabilities and funding